Cargando…

Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients

Age at diagnosis, stage, and MYCN amplification are the cornerstones of the risk-stratification score of neuroblastoma that enables defining patients at low- and high risk. Refinement of this stratification is needed to optimize standard treatment and to plan future clinical trials. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gattolliat, Charles-Henry, Le Teuff, Gwénaël, Combaret, Valérie, Mussard, Eugénie, Valteau-Couanet, Dominique, Busson, Pierre, Bénard, Jean, Douc-Rasy, Sétha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303168/ https://www.ncbi.nlm.nih.gov/pubmed/24931722 http://dx.doi.org/10.1002/cam4.264

Ejemplares similares

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

Netrin-1 acts as a survival factor for aggressive neuroblastoma
por: Delloye-Bourgeois, Céline, et al.
Publicado: (2009)

p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells
por: Horvilleur, Emilie, et al.
Publicado: (2008)

Expression of C-terminal deleted p53 isoforms in neuroblastoma
por: Goldschneider, David, et al.
Publicado: (2006)

p21(Waf1 )expression is regulated by nuclear intermediate filament vimentin in neuroblastoma
por: Mergui, Xénia, et al.
Publicado: (2010)

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
por: Bellini, Angela, et al.
Publicado: (2019)

Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
por: Huybrechts, Sophie, et al.
Publicado: (2020)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood
por: Combaret, Valérie, et al.
Publicado: (2015)

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
por: Boland, I, et al.
Publicado: (1999)

TRIM proteins in neuroblastoma
por: Xu, Yonghu, et al.
Publicado: (2019)

Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)

Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
por: Rubie, H, et al.
Publicado: (2003)

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
por: Maritaz, Christophe, et al.
Publicado: (2018)

Parental imprinting
por: Capitani, E, et al.
Publicado: (2023)

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
por: Amoroso, Loredana, et al.
Publicado: (2018)

MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children
por: Jiang, Susu, et al.
Publicado: (2023)

MiRNA-423 rs6505162 and miRNA-6811 rs2292879 SNP associated with lung cancer in Hainan, China
por: Zhou, Jing, et al.
Publicado: (2023)

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
por: Schleiermacher, G, et al.
Publicado: (2007)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD(2) antibody ch14.18/CHO
por: Mueller, Ina, et al.
Publicado: (2017)

WANTED: Better neuroblastoma biomarkers and better stratification
por: London, Wendy B.
Publicado: (2022)

TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study
por: Fang, Yuan, et al.
Publicado: (2020)

Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
por: Lv, Peng, et al.
Publicado: (2020)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Regarding human cytomegalovirus in neuroblastoma
por: Forslund, Ola, et al.
Publicado: (2014)

Risk stratification of adult T‐cell leukemia/lymphoma using immunophenotyping
por: Kagdi, Huseini H., et al.
Publicado: (2016)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

Imprinting and flexibility in human face cognition
por: Marcinkowska, Urszula M., et al.
Publicado: (2016)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
por: Bellini, Angela, et al.
Publicado: (2021)

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
por: Saulnier Sholler, Giselle L, et al.
Publicado: (2015)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

Genetic variation associated with childhood and adult stature and risk of MYCN‐amplified neuroblastoma
por: Semmes, Eleanor C., et al.
Publicado: (2020)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer
por: Yan, Li-rong, et al.
Publicado: (2021)

Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
por: Hu, Maogui, et al.
Publicado: (2021)

Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors
por: Brunner, Clemens, et al.
Publicado: (2016)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma
por: Kawano, Kumi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a6gtmjgbc859gsr7vc61clknmb